A rare case and a rapid tumor response to therapy: Dramatic reduction in tumor size during octreotide treatment in a patient with TSH-secreting pituitary macroadenoma

By Erem Cihangir   Hacihasanoglu Arif   Sari Ahmet   Ersöz Halil   Ukinç Kubilay   Fidan Sami  

Endocrine Journal, Vol. 25, Iss. 2, 2004-11 ,pp. : 141-145

Humana Press, Inc

Access to resources Recommend Favorite

Octreotide effect on growth hormone and somatostatin subtype 2 receptor mRNAs of the human pituitary somatotroph adenomas

By Stefaneanu Lucia   Kovacs Kalman   Thapar Kamal   Horvath Eva   Melmed Shlomo   Greenman Yona  

Endocrine Pathology, Vol. 11, Iss. 1, 2000-03 ,pp. : 41-48

Humana Press, Inc

Access to resources Recommend Favorite

Clinical and Molecular Features of a TSH-Secreting Pituitary Microadenoma

By Usui Takeshi   Izawa Shoichiro   Sano Toshiaki   Tagami Tetsuya   Nagata Daisuke   Shimatsu Akira   Takahashi Jun   Naruse Mitsuhide  

Pituitary, Vol. 8, Iss. 2, 2005-04 ,pp. : 127-134

Springer Publishing Company

Access to resources Recommend Favorite

Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience

By Brzana Jessica   Yedinak Chris   Gultekin Sakir   Delashaw Johnny   Fleseriu Maria  

Pituitary, Vol. 16, Iss. 4, 2013-12 ,pp. : 490-498

Springer Publishing Company

Access to resources Recommend Favorite

Differential Expression of the Five Somatostatin Receptor Subtypes in Human Benign and Malignant Insulinomas – Predominance of Receptor Subtype 4

By Portela-Gomes Guida   Stridsberg Mats   Grimelius Lars   Rorstad Otto   Janson Eva  

Endocrine Pathology, Vol. 18, Iss. 2, 2007-05 ,pp. : 79-85

Humana Press, Inc

Access to resources Recommend Favorite